Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StartPoint Advisors is a China-focused boutique healthcare investment bank and financial advisory firm serving pharmaceutical, biotech, medtech, diagnostics, digital health, and healthcare services companies. The firm appears to focus on equity financing, mergers and acquisitions, and licensing or partnering transactions rather than developing its own therapeutics. Publicly available profiles indicate it was founded in 2020, operates from major Chinese hubs including Beijing and Shanghai, and has advised on numerous healthcare transactions. Although it is active in the life sciences ecosystem, it is not itself a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Start Point Advisors.